anti-CD79 antibodies (National Jewish Health)

N/A

Report date: 2025/03/14 16:48:23

Base Information

Drug Nameanti-CD79 antibodies (National Jewish Health)
Drug Alias NameCurly-14
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCD79 antigens antagonists
TargetsCD79 antigens
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Jewish Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Jewish Health
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A